Clinical Immunology, Neuropharmacology and Drug Development

Emerging Neuroprotective Agents

This track invites submissions on the development and testing of neuroprotective agents aimed at preventing or mitigating neuronal damage in neurological diseases. Researchers should focus on novel compounds, mechanisms of neuroprotection, and clinical trial outcomes. The track will cover a range of conditions, including stroke, traumatic brain injury, and neurodegenerative diseases, with an emphasis on translating neuroprotective strategies into clinical practice. Attendees will learn about the latest advances in neuroprotection and the potential for these agents to improve patient outcomes.